BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Deals

  Johnson & Johnson and Crucell N.V. Progress Update: Expect to Commence Public Offer Prior to 10 December 2010

  December 1, 2010

   · 

  8 min read
• Business

  Prometheus Laboratories Inc. Extends Distribution Agreement for ENTOCORT(R) EC (budesonide) Capsules with AstraZeneca LP

  December 1, 2010

   · 

  5 min read
• Business

  Janssen Pharmaceutica N.V., GE Healthcare Announce Collaboration to Develop Diagnostic Biosignatures for Pre-Symptomatic Identification of Alzheimer’s Disease

  December 1, 2010

   · 

  3 min read
• Biotech Bay

  Biocontrol Noninvasive Monitoring Patents to be Auctioned

  December 1, 2010

   · 

  3 min read
• BioMidwest

  News From the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago

  December 1, 2010

   · 

  3 min read
• Policy

  Orbus Neich Issues Statement on Boston Scientific Corporation’s Unsuccessful Retaliatory Litigation Efforts in the Netherlands

  December 1, 2010

   · 

  4 min read
• Business

  Tolerx, Inc. and the Cancer Research Institute Enter Collaboration to Accelerate Development of TRX518, a First-in-Class Anti-GITR Antibody for Cancer Treatment

  December 1, 2010

   · 

  5 min read
• Drug Development

  Cempra Pharmaceuticals, Inc.: Molecular Mechanisms That Could Explain Unique Adverse Events Observed in Patients Treated With the Antibiotic Telithromycin

  December 1, 2010

   · 

  5 min read
• Biotech Beach

  Isis Pharmaceuticals, Inc. to Present at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference

  December 1, 2010

   · 

  1 min read
• Pharm Country

  PTC Therapeutics, Inc.: Observational Data From One-Year Follow-up Study Validate Six-Minute Walk Distance as an Outcome Measure in Duchenne and Becker Muscular Dystrophy

  December 1, 2010

   · 

  6 min read